Hanmi Pharm
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · South Korea · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
14 Wiryeseong-daero, Seoul, Seoul, South...Phone Number
+82 24109114Website
www.hanmipharm.comRevenue
$1.1 BillionStock Symbol
128940Industry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Hanmi Pharm
Hanmi Pharmaceutical is a research and development focused biopharmaceutical company headquartered in Seoul, South Korea. Founded by a pharmacist with a strong emphasis on innovation and scientific advancement, the company is dedicated to discovering, developing, and commercializing new medicines that address unmet medical needs. It operates with a philosophy centered on improving human health through technology-driven pharmaceutical innovation and value creation.Explore more
Hanmi Pharm Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Hanmi Pharm your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Hanmi Pharm had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Hanmi Pharm recently announced quarterly report
Hanmi Pharm, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Hanmi Pharm launches new products
Check if Hanmi Pharm has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Hanmi Pharm is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Hanmi Pharm
Funding: Get notified immidiatlly once Hanmi Pharm has new funding data
Recommended Actions
Reach out to Masked Content who joined Hanmi Pharm as Masked Content
Find 2 more new buyers
Company Profile Activity
Activity Insights
Hanmi Pharm is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Hanmi Pharm is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Hanmi Pharm.
Hanmi Pharm Tech Stack
A closer look at the technologies used by Hanmi Pharm
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Project
Laboratory Operations, Medical Research, Clinical Operations
Hanmi Pharm News & Media
Hanmi Pharmaceutical Partners with Organon to Export Combination Therapies to Southeast Asia
Hanmi announced that it has signed a supply agreement with Organon to export three combination medicines for the Malaysian and Philippine markets.Aptose Biosciences Announces Amendment to Arrangement Agreement and Details of Postponed Special Meeting of Shareholders
Aptose Biosciences Announces Amendment to Arrangement Agreement and Details of Postponed Special Meeting of ShareholdersHealth Hope Pharma Enters into Exclusive Licensing Agreement with Gilead Sciences
HHP and Hanmi will grant Gilead exclusive license to encequidar, and provide access to drug supply HONG KONG, Sept. 29, 2025 /PRNewswire/ -- Health Hope Pharma Limited ("HHP") today announced that it has entered into a global licensing and collaboration agreement with Gilead Sciences, Inc. ("Gilead") for encequidar, a first-in-class P-glycoprotein ("P-gp") inhibitor in the field of virology. HHP is currently exploring the potential of using encequidar to develop oral drug formulations across mulHanmi's Oral Delivery Platform Compound Licensed to Gilead
Hanmi and HHP will grant Gilead an exclusive license to Encequidar and provide access to drug supply. SEOUL, South Korea, Sept. 29, 2025 /PRNewswire/ -- Hanmi Pharm announced on September 29 that it has entered into a global licensing and collaboration agreement with Gilead Sciences, Inc. ("Gilead") and Health Hope Pharma ("HHP") granting Gilead the exclusive rights to develop and commercialize encequidar. Orascovery™ is an innovative oral drug delivery proprietary platform owned by Hanmi that e
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Hanmi Pharm
Sign Up For FreeTo access detailed company insights
Hanmi Pharmaceutical is a research and development focused biopharmaceutical company headquartered in Seoul, South Korea. Founded by a pharmacist with a strong emphasis on innovation and scientific advancement, the company is dedicated to discovering, developing, and commercializing new medicines that address unmet medical needs. It operates with a... Read More
